Vania Modesto-Lowe, MD, MPH

Quinnipiac University, North Haven, Connecticut

  • 21Articles
  • 53.9KReads
  • 2021–2026Active
  • 23Collaborators
  • 4Citations

About

Vania Modesto-Lowe, MD, MPH is affiliated with Quinnipiac University, North Haven, Connecticut. Vania Modesto-Lowe has authored or co-authored 21 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2021 and 2026. Their work focuses on Addiction, Attention-Deficit/Hyperactivity Disorder, Child and Adolescent Psychiatry, COVID, and Depression (MDD).

Publications

PCC
Zeroing in on Xylazine
Letter to the Editor

Zeroing in on Xylazine

August 15, 2024

Dr Kaur and colleagues discuss the need to raise awareness among US public and health care professionals about xylazine due to its infiltration into the illicit drug supply.
, ,
PCC
Fentanyl Test Strips and Drug Use Modification
Letter to the Editor

Fentanyl Test Strips and Drug Use Modification

May 14, 2024

The authors explore the use of fentanyl test strips as a harm reduction tactic to identify contaminated substances for people who use illicit drugs.
, ,
PCC
Do Not Overlook Bupropion Misuse
Letter to the Editor

Do Not Overlook Bupropion Misuse

April 30, 2024

Jasleen Kaur, MD, and colleagues comment on a case report published in the PCC.
, ,
PCC
Deprescribing Benzodiazepines: Is Harm Reduction Enough?
Letter to the Editor

Deprescribing Benzodiazepines: Is Harm Reduction Enough?

December 28, 2023

Vania Modesto-Lowe, MD, MPH, and Claire N. Aurilio, BS, comment on a recent publication in the PCC.
,
PCC
Social Determinants of Health and Extended-Release Naltrexone
Brief Report

Social Determinants of Health and Extended-Release Naltrexone

June 29, 2023

Patients with alcohol use disorder are at high risk of treatment nonadherence and readmission. While ER naltrexone can help prevent relapse for 28 days, they may face homelessness for...
,
PCC
Buprenorphine Maintenance in the Fentanyl Era
Letter to the Editor

Buprenorphine Maintenance in the Fentanyl Era

February 14, 2023

Methods to foster patient adherence and physician acceptability of buprenorphine maintenance are needed to incorporate this treatment into primary care for fentanyl users.
,
PCC
Mindfulness Training in Opioid Withdrawal
Letter to the Editor

Mindfulness Training in Opioid Withdrawal

June 30, 2022

In this letter to the editor, the authors comment on an article published recently in the PCC.
, ,
PCC
The Hidden Curriculum in Addiction Training
Letter to the Editor

The Hidden Curriculum in Addiction Training

March 24, 2022

In this letter to the editor, the authors discuss the stigma associated with addiction treatment, as well as strategies to increase addiction literacy among physicians.
,
JCP
Letter to the Editor

Can You Teach Resilience?

July 27, 2021

This Letter to the Editor comments on two recent Journal articles that discuss coping responses and resilience among health care workers during the COVID-19 pandemic.
, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe